KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Ratio (2016 - 2025)

Exact Sciences (EXAS) has disclosed Equity Ratio for 16 consecutive years, with 0.41 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 1.1% to 0.41 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.41, a 1.1% increase, with the full-year FY2025 number at 0.41, up 1.1% from a year prior.
  • Equity Ratio was 0.41 for Q4 2025 at Exact Sciences, down from 0.42 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.54 in Q1 2021 to a low of 0.41 in Q4 2024.
  • A 5-year average of 0.48 and a median of 0.49 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 30.73% in 2021, then dropped 16.63% in 2024.
  • Exact Sciences' Equity Ratio stood at 0.51 in 2021, then fell by 3.56% to 0.49 in 2022, then decreased by 0.55% to 0.49 in 2023, then dropped by 16.63% to 0.41 in 2024, then increased by 1.1% to 0.41 in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Equity Ratio are 0.41 (Q4 2025), 0.42 (Q3 2025), and 0.43 (Q2 2025).